Athira Pharma
ATHA
ATHA
106 hedge funds and large institutions have $342M invested in Athira Pharma in 2021 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 27 increasing their positions, 34 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
3.44% more ownership
Funds ownership: 66.8% → 70.24% (+3.4%)
21% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 34
Holders
106
Holding in Top 10
–
Calls
$24.1M
Puts
$13.2M
Top Buyers
| 1 | +$6.18M | |
| 2 | +$5.82M | |
| 3 | +$4.51M | |
| 4 |
PFO
Pathstone Family Office
Englewood,
New Jersey
|
+$3.85M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.44M |
Top Sellers
| 1 | -$4.85M | |
| 2 | -$3.03M | |
| 3 | -$2.93M | |
| 4 |
VA
VR Adviser
New York
|
-$2.56M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.38M |